Switch to second-line ART in West African routine care: Incidence and reasons for switching

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 23, Issue 1, 2011, Pages 75-78

  Landier, Jordi ^a   Akonde, Alain ^b   Pizzocolo, Cecilia ^c   Haidara, Ibrahim ^d   Drabo, Mahamadou ^b   Pizarro, Louis ^c   Fontanet, Arnaud ^a   Katlama, Christine ^c   Madec, Yoann ^a  

^a INSTITUT PASTEUR   (France)

^b Solthis ^*  (Mali)

^c Solthis   (France)

^d H pital Régional de Ségou   (Mali)

Author keywords

Africa; ART; HIV; second line; treatment modification

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AFRICA; ARTICLE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; FEMALE; HEALTH CARE DELIVERY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MOTIVATION; PATIENT CARE; PATIENT MONITORING; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT FAILURE;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DRUG SUBSTITUTION; EPIDEMIOLOGIC METHODS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; TREATMENT FAILURE;

EID: 78651357978     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540121.2010.498867     Document Type: Article

References (7)

1. De Beaudrap, P., Etard, J.F., Gueye, F.N., Gueye, M., Landman, R., Girard, P.M., . . . Delaporte, E. (2008). Long-term efficacy and tolerance of Efavirenz- and Nevirapine-containing regimens in adult HIV type 1 Senegalese patients. AIDS Research and Human Retroviruses, 24, 753-760.
2. Ivers, L.C., Kendrick, D., & Doucette, K. (2005). Efficacy of antiretroviral therapy programs in resource-poor settings: A meta-analysis of the published literature. Clinical Infectious Diseases, 41, 217-224.
3. Kiguba, R., Byakika-Tusiime, J., Karamagi, C., Ssali, F., Mugyenyi, P., & Katabira, E. (2007). Discontinuation and modification of highly active antiretroviral therapy in HIV-infected ugandans: Prevalence and associated factors. Journal of Acquired Immune Deficiency Syndromes, 45, 218-223.
4. Orrell, C., Harling, G., Lawn, S.D., Kaplan, R.,McNally,M., Bekker, L.G., & Wood, R. (2007). Conservation of first-line treatment regimen where therapeutic options are limited. Antiviral Therapy, 12, 83-88.
5. Pujades-Rodriguez, M., O'Brien, D., Humblet, P., & Calmy, A. (2008). Second-line antiretroviral therapy in resource-limited settings: The experience of Médecins Sans Frontiè res. AIDS, 22, 1305-1312.
6. Toure, S., Kouadio, B., Seyler, C., Traore, M., Dakoury- Dogbo, N., Duvignac, J., . . . Anglaret, X. (2008). Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cǒ te d'Ivoire: 2-year outcomes and determinants. AIDS, 22, 873-882.
7. World Health Organization (2006). Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach; 2006 revision. Retrieved from 78 J. Landier et al.